Switch to:
More From Other Websites
Biotech Surge: How To Survive In A Volatile Market Apr 28 2017
Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting Apr 20 2017
How Nektar Therapeutics' Latest Drug Could Shake Up the Market for Pain Medicine Apr 19 2017
Can Drugmakers Cure the Opioid Crisis? Apr 18 2017
Today's Research Reports on Biotech Stocks to Watch: Nektar Therapeutics and Clovis Oncology Apr 10 2017
The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar... Apr 07 2017
Nektar Therapeutics (NKTR) Up 57.2% Since Earnings Report: Can It Continue? Apr 07 2017
3 of the Best & Worst Performing Drug Stocks of Q1 Apr 06 2017
Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American... Apr 04 2017
Cramer's lightning round: If we get two rate hikes, this stock's a good buy Apr 03 2017
3 Revolutionary Drugs for Chronic Pain Mar 30 2017
Western Digital, Nektar Therapeutics And Two More Stocks Breaking Out Mar 30 2017
Harry Boxer’s five technology and biotechnology stocks to watch Mar 29 2017
Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell... Mar 27 2017
Trump is tapping Chris Christie to tackle the opioid epidemic — here's a fix scientists hope he'll... Mar 27 2017
Could Nektar Therapeutics Be Worth More? Mar 23 2017
Nektar Therapeutics (NKTR): Here’s What Just Happened Mar 21 2017
Nektar's Pain Drug Positive in Phase III Study; Shares Gain Mar 21 2017
Stocks of Nektar Therapeutics and CytomX Therapeutics Rise on FDA Trial News Mar 21 2017
After-hours buzz: ESPR, NKTR, MMSI & more Mar 20 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK